The Early Histological Effects of Intravesical Instillation of Platelet- Rich Plasma in Cystitis Models
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: To evaluate the early histological effects of the intravesical instillation of platelet-rich plasma (PRP) in rabbit models of interstitial and hemorrhagic cystitis. Methods: Thirty-six rabbits were classified into 6 groups: saline (S), S+PRP, hydrochloric acid (HCl), HCl+PRP, cyclophosphamide (CyP), and CyP+PRP. At 48 hours after induction, PRP was prepared and intravesically administered to the S+PRP, HCl+PRP, and CyP+PRP groups. Bladder sections were stained with toluidine blue for mast cell counting and with hematoxylin and eosin for histopathology and mitotic index determination. The proliferation index was determined by proliferating cell nuclear antigen (PCNA) immunolabeling. The nonparametric Mann-Whitney U-test was used for statistical analysis. Results: No abnormalities were observed in the S group, whereas increased interstitial edema and increased average mitotic and proliferation indices were observed in the S+PRP group (P=0.023, P=0.004, and P=0.009, respectively). Intense epithelial loss, hemorrhage, and leukocyte infiltration were detected in the HCl and HCl+PRP groups, whereas a significantly increased average mitotic index was observed in the HCl+PRP group (P=0.002). When compared with its CyP counterpart, a significant reduction in hemorrhage and an increase in leukocyte infiltration and mitotic index were observed in the CyP+PRP group (P=0.006, P=0.038, and P=0.002, respectively). In addition, PCNA staining revealed a significantly increased proliferation index in the HCl+PRP and CyP+PRP groups (P=0.032 and P=0.015, respectively). Conclusions: The intravesical instillation of PRP increased the mitotic index in the saline and cyclophosphamide groups while decreasing macroscopic bleeding.
Abstract
Purpose: To evaluate the early histological effects of the intravesical instillation of platelet-rich plasma (PRP) in rabbit models of interstitial and hemorrhagic cystitis. Methods: Thirty-six rabbits were classified into 6 groups: saline (S), S+PRP, hydrochloric acid (HCl), HCl+PRP, cyclophosphamide (CyP), and CyP+PRP. At 48 hours after induction, PRP was prepared and intravesically administered to the S+PRP, HCl+PRP, and CyP+PRP groups. Bladder sections were stained with toluidine blue for mast cell counting and with hematoxylin and eosin for histopathology and mitotic index determination. The proliferation index was determined by proliferating cell nuclear antigen (PCNA) immunolabeling. The nonparametric Mann-Whitney U-test was used for statistical analysis. Results: No abnormalities were observed in the S group, whereas increased interstitial edema and increased average mitotic and proliferation indices were observed in the S+PRP group (P=0.023, P=0.004, and P=0.009, respectively). Intense epithelial loss, hemorrhage, and leukocyte infiltration were detected in the HCl and HCl+PRP groups, whereas a significantly increased average mitotic index was observed in the HCl+PRP group (P=0.002). When compared with its CyP counterpart, a significant reduction in hemorrhage and an increase in leukocyte infiltration and mitotic index were observed in the CyP+PRP group (P=0.006, P=0.038, and P=0.002, respectively). In addition, PCNA staining revealed a significantly increased proliferation index in the HCl+PRP and CyP+PRP groups (P=0.032 and P=0.015, respectively). Conclusions: The intravesical instillation of PRP increased the mitotic index in the saline and cyclophosphamide groups while decreasing macroscopic bleeding.
참고문헌 (19)
- Oravisto KJ, "Epidemiology of interstitial cystitis", Ann Chir Gynaecol Fenn, 64, pp.75~77 (1975)
- Garg AK, "The use of platelet-rich plasma to enhance the success of bone grafts around dental implants", Dent Implantol Update, 11, pp.17~21 (2000)
- Marx RE, "Platelet-rich plasma: evidence to support its use", J Oral Maxillofac Surg, 62, pp.489~496 (2004)
- Sánchez AR, "Is platelet-rich plasma the perfect enhancement factor? A current review", Int J Oral Maxillofac Implants, 18, pp.93~103 (2003)
- Matsumoto S, "The functional and structural response to distention of the rabbit whole bladder in vitro", J Urol, 168, pp.2677~2681 (2002)
- Nagae M, "Intervertebral disc regeneration using platelet-rich plasma and biodegradable gelatin hydrogel microspheres", Tissue Eng, 13, pp.147~158 (2007)
- chronic cyclophosphamide treatment, "J Physiol Pharmacol", 2010, 477~482
- Fadare O, "Variations of mitotic index in normal and dysplastic squamous epithelium of the uterine cervix as a function of endometrial maturation", Mod Pathol, 20, pp.1000~1008 (2007)
- Fall M, "EAU guidelines on chronic pelvic pain", Eur Urol, 57, pp.35~48 (2010)
- Parsons CL, "Bladder surface glycosaminoglycans: an epithelial permeability barrier", J Urol, 143, pp.139~142 (1990)
- Rivas DA, "Molecular marker for development of interstitial cystitis in rat model: isoactin gene expression", J Urol, 157, pp.1937~1940 (1997)
- Jost SP, "Renewal of normal urothelium in adult mice", Virchows Arch B Cell Pathol Incl Mol Pathol, 51, pp.65~70 (1986)
- Veranic P, "Jezernik K. Rapid differentiation of superficial urothelial cells after chitosaninduced desquamation", Histochem Cell Biol, 131, pp.129~139 (2009)
- Romih R, "Endocytosis during postnatal differentiation in superficial cells of the mouse urinary bladder epithelium", Cell Biol Int, 18, pp.663~668 (1994)
- Jezernik K, "Urothelial cell detachment and differentiation in urinary bladder", Pflugers Arch, 439(3 Suppl), pp.R135~R136 (2000)
- Kajikawa Y, "Platelet-rich plasma enhances the initial mobilization of circulation-derived cells for tendon healing", J Cell Physiol, 215, pp.837~845 (2008)
- Trink A, "A randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata", Br J Dermatol, 169, pp.690~694 (2013)
- Carlson NE, "Platelet-rich plasma: clinical applications in dentistry", J Am Dent Assoc, 133, pp.1383~1386 (2002)
- Shirvan MK, "A novel method for iatrogenic vesicovaginal fistula treatment: autologous platelet rich plasma injection and platelet rich fibrin glue interposition", J Urol, 189, pp.2125~2129 (2013)